Clinical trial
Prospective Cohort Study of the Effect of Serum HBV DNA Level on Intrahepatic Recurrence in Locally Treatable, HBV-related HCC Patients
NCT00397540 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Cohort Study of the Effect of Serum HBV DNA Level on Intrahepatic Recurrence in Locally Treatable, HBV-related HCC Patients
- Lead sponsor
- Seoul National University Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2004
- Completion date
- May 31, 2011
- Enrollment
- 145 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
carcinoma, hepatocellular, chronic hepatitis b